コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 phase transition (MIT), the origin of which is still under debate.
2 owever, the role of allergy in severe asthma is still under debate.
3 r, the negative effect of regular-fat cheese is still under debate.
4 a (TGF-beta) signaling in cancer progression is still under debate.
5 he mechanochemical cycle of kinesin-14 (ncd) is still under debate.
6 r dielectric relaxation, remains unclear and is still under debate.
7 rigin of the intrinsic CA1 gamma oscillation is still under debate.
8 bers of the family and their role in disease is still under debate.
9 on soil organic matter (SOM) mineralization is still under debate.
10 tivation influences such a control hierarchy is still under debate.
11 , its biochemical and physiological function is still under debate.
12 living excited states whose molecular nature is still under debate.
13 of transcription, but its exact target site is still under debate.
14 The identity of this factor is still under debate.
15 nase of STAT5, the Janus kinase JAK2, in CML is still under debate.
16 tors of CVEs, but the most powerful variable is still under debate.
17 ivities and DNA binding during translocation is still under debate.
18 ry which leads to the observed fragmentation is still under debate.
19 aintenance of sex among microbial eukaryotes is still under debate.
20 les, and for which the optimal method for GS is still under debate.
21 , or pattern of intake is the most important is still under debate.
22 ccumulation of Ca(2+), its precise mechanism is still under debate.
23 e source of this spatial nonlinear summation is still under debate.
24 the enzyme in mitochondria and chloroplasts is still under debate.
25 o anti-cancer drugs, its mechanism of action is still under debate.
26 sis underlying this immune-mediated response is still under debate.
27 chanism underlying this regenerative process is still under debate.
28 ontributes to CNS inflammation and pathology is still under debate.
29 Why deltaR agonists show low efficacy is still under debate.
30 tion and the role of NR2A on CSD propagation is still under debate.
31 tural evolution and multiplication mechanism are still under debate.
32 be growth, but its localization and function are still under debate.
33 switching induced by the electrical current are still under debate.
34 ponsible for the activation of the substrate are still under debate.
35 sms of abiotic stress mitigation by isoprene are still under debate.
36 rising from partially screened interactions, are still under debate.
37 y remains elusive and their cellular origins are still under debate.
38 nd the geographical extent of the deposition are still under debate.
39 cell-penetrating peptides through membranes are still under debate.
40 e formation and maintenance of PIP2 clusters are still under debate.
41 boundaries of the UIS are yet not clear and are still under debate.
42 usion, and fission, whose precise mechanisms are still under debate.
43 the ultimate causes for the climatic changes are still under debate.
44 mal strategy for treating nonculprit disease is currently under debate.
45 e of vaccines to prevent and control cholera is currently under debate.
46 rce of this decline in cognitive performance is currently under debate.
47 multiple sclerosis and the leukodystrophies, is currently under debate.
48 pplies in the event of an influenza pandemic is currently under debate.
49 receptor pathway activated in this response is currently under debate.
50 e proteins after insertion into the bilayer, is currently under debate.
51 ng progression to generalized myasthenia gravis is still under debate and needs to be further studied
54 ance, the involvement of the chain mechanism is still under debate) because of the lack of structural
55 chanism of Ca(2+)-sensing by synaptotagmin I is still under debate despite intensive investigation us
56 in this area, the existence of these domains is still under debate due to the characteristics of the
57 eric receptor state for G protein activation is currently under debate for class A rhodopsin-like GPC
59 However, the validity of this categorization is still under debate mainly because of the lack of pote
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。